These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36366851)

  • 1. Physical Characterization and Safety Evaluation of Folic Acid-conjugated Mesoporous Silica Nanoparticles Loaded with Rhodojaponin III.
    Yang Q; Zhao C; Yang J; Zhao J; Feng Y; Liu M; Zhang J
    Curr Drug Deliv; 2023; 20(10):1559-1568. PubMed ID: 36366851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhodojaponin III-Loaded Chitosan Derivatives-Modified Solid Lipid Nanoparticles for Multimodal Antinociceptive Effects in vivo.
    Yang Q; Yang J; Sun S; Zhao J; Liang S; Feng Y; Liu M; Zhang J
    Int J Nanomedicine; 2022; 17():3633-3653. PubMed ID: 35996527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
    Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
    Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
    Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
    Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
    Saroj S; Rajput SJ
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
    Ma B; He L; You Y; Mo J; Chen T
    Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
    Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic Acid-Polyethyleneimine Functionalized Mesoporous Silica Nanoparticles as a Controlled Release Nanocarrier.
    Park J; Park SS; Jo NJ; Ha CS
    J Nanosci Nanotechnol; 2019 Oct; 19(10):6217-6224. PubMed ID: 31026940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
    Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
    Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Rhodojaponin III from Rhododendron molle G. Don on oral antinociceptive activity, mechanism of action, and subacute toxicity in rodents.
    Yang J; Yang Q; Zhao J; Sun S; Liu M; Wang Y; Feng Y; Zhang J
    J Ethnopharmacol; 2022 Aug; 294():115347. PubMed ID: 35533915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z; Zhang Y; Feng N
    Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.
    Wu Y; Ge P; Xu W; Li M; Kang Q; Zhang X; Xie J
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110386. PubMed ID: 31923940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration.
    Gong S; Lang S; Wang Y; Li X; Tian A; Ma J; Ma X
    Int J Nanomedicine; 2024; 19():6337-6358. PubMed ID: 38946884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive and targeted delivery of chrysin via folic acid-functionalized mesoporous silica nanocarrier for breast cancer therapy.
    Ghosh N; Kundu M; Ghosh S; Das AK; De S; Das J; Sil PC
    Int J Pharm; 2023 Jan; 631():122555. PubMed ID: 36586636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.
    AbouAitah K; Swiderska-Sroda A; Farghali AA; Wojnarowicz J; Stefanek A; Gierlotka S; Opalinska A; Allayeh AK; Ciach T; Lojkowski W
    Oncotarget; 2018 May; 9(41):26466-26490. PubMed ID: 29899871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of RGD Peptide/Folate Acid Double-Targeted Mesoporous Silica Nanoparticles and Its Application in Human Breast Cancer MCF-7 Cells.
    Yan H; You Y; Li X; Liu L; Guo F; Zhang Q; Liu D; Tong Y; Ding S; Wang J
    Front Pharmacol; 2020; 11():898. PubMed ID: 32612532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An injectable mesoporous silica-based analgesic delivery system prolongs the duration of sciatic nerve block in mice with minimal toxicity.
    Wang H; Zhang Y; Xu X; Wang A
    Acta Biomater; 2021 Nov; 135():638-649. PubMed ID: 34520884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
    Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
    Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.